Search Results - "Petrák, B"

Torcular dural sinus malformations: a single-center case series and a review of literature by Liby, Petr, Lomachinsky, V., Petrak, B., Kyncl, M., Charvat, F., Padr, R., Tichy, M.

“…Introduction Torcular dural sinus malformations (tDSMs) are rare vascular pathologies with various anatomoclinical pictures and prognosis. We analyzed our case…”
Get full text

Torcular dural sinus malformations: a grading system proposal by Liby, P., Lomachinsky, V., Petrak, B., Kyncl, M., Montarroyos, U.R., Tichy, M.

“…Background Torcular dural sinus malformations (tDSMs) are congenital complex vascular anomalies often referred as a single unit. Nevertheless, they possess…”
Get full text

Isotopic gas analysis through Purcell cavity enhanced Raman scattering by Petrak, B., Cooper, J., Konthasinghe, K., Peiris, M., Djeu, N., Hopkins, A. J., Muller, A.

“…Purcell enhanced Raman scattering (PERS) by means of a doubly resonant Fabry-Perot microcavity (mode volume ≈ 100 μm3 and finesse ≈ 30 000) has been…”
Get full text

Two-color photon correlations of the light scattered by a quantum dot by Peiris, M., Petrak, B., Konthasinghe, K., Yu, Y., Niu, Z. C., Muller, A.

“…Two-color second-order correlations of the light scattered near-resonantly by a quantum dot were measured by means of spectrally filtered coincidence…”
Get full text

P139 – 3023: First epileptic seizures in children followed for cardiac rhabdomyomas and tuberous sclerosis by Petrak, B, Benova, B, Tomek, V, Valkovicova, R, Glombova, M, Gabera, A, Krsek, P

“…Objective Tuberous sclerosis (TSC) is a congenital multisystemic disease affecting also nervous system; including early onset of epilepsy and risk of mental…”
Get full text

PP15.3 – 2545: Everolimus for patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Results from an expanded access study by Fogarasi, A, De Waele, L, Bartalini, G, Jóźwiak, S, Laforgia, N, Verhelst, H, Petrak, B, Pedespan, J.M, Witt, O, Castellana, R, Crippa, S, Gislimberti, G, Gyorsok, Z

“…Objective Everolimus For Fast Expanded aCcess in TSC SEGA (EFFECTS) study was designed to provide early access to everolimus for patients with SEGA associated…”
Get full text

Is there any relation between paternal age and sporadic cases of neurofibromatosis Von Recklinghausen type 1? by Snajderova, M, Petrak, B, Mardesic, T, Havlovicova, M, Zemkova, D

Get full text

The face of Job by Borges, Wellington G., Hensley, Teri, Carey, John C., Petrak, Betty A., Hill, Harry R.

“…We evaluated facial features in 9 patients from 7 kindreds with Job syndrome. Consistent features included prominent forehead with deep-set eyes, increased…”
Get full text

Immunoadsorption in thrombangiitis obliterans: a promising therapeutic option: results of a consecutive patient cohort treated in clinical routine care by Klein-Weigel, P F, Köning, C, Härtwig, A, Krüger, K, Gutsche-Petrak, B, Dreusicke, S, Thieme, U, Enke-Melzer, K, Urbach, B, Kron, J

“…Thrombangiitis obliterans or Buerger's disease is a segmental inflammatory disease affecting small and medium-sized veins and arteries, which most often…”
Get more information

P059 Follow-up of evoked potential changes related to MRI findings in patients with neurofibromatosis von Recklinghausen type 1 (NF1) by Kraus, J, Petrak, B, Kaluzova, M, Lisy, J

Get full text

Secondary medical prevention in patients with peripheral arterial disease - prescriptions of vascular surgeons and medical doctors (angiologists) in a multidisciplinary vascular centre by Klein-Weigel, P F, Gutsche-Petrak, B, Wolbergs, S, Köning, C, Flessenkamper, I

“…We compared medical secondary prevention in patients with peripheral arterial disease stage II (Fontaine) located in the femoro-popliteal artery managed by…”
Get more information

O9-1 Frequency, localization and clinical aspects of the brain tumors in children with neurofibromatosis von Recklinghausen type 1 by Kaluzova, M, Petrak, B, Lisy, J, Radvanska, J, Schwabova, J

Get full text

Evoked potential changes related to MRI findings in patients with neurofibromatosis von Recklinghausen type 1 by Kraus, J, Petrak, B, Kaluzova, M, Lisy, J

Get full text

Plasmatic value of the neuron-specific enolase, protein S100B and anti-vimentin antibodies in children with tuberous sclerosis complex by Petrak, B, Kotaska, K, Kaluzova, M

Get full text

P054 Signification of the follow-up of children with congenital cardiac rhabdomyomas for early diagnosis of the tuberous sclerosis by Petrak, B, Cerny, M, Chaloupecky, V, Kyncl, M, Kaluzova, M, Jahodova, A

Get full text

Diagnostic efficiency of anti-vimentin antibodies and neuron-specific enolase in patients with neurofibromatosis von Recklinghausen type 1 by Kotaska, K, Petrak, B, Kukacka, J, Kraus, J, Pechova, M, Prusa, R

Get full text

The development of obstructive hydrocephalus due to aqueductal stenosis in a boy with neurofibromatosis von Recklinghausen type 1 by Kaluzova, M, Petrak, B, Bendova, S, Lisy, J, Kraus, J, Zackova, J

Get full text

Circulating nerve growth factor in primary and secondary Raynaud's syndrome - results of a pilot study by Klein-Weigel, P, Gutsche-Petrak, B, Humpel, C, Riemekasten, G, Ivanov, S, Heidrich, H

“…In this pilot study we examined circulating concentrations of nerve growth factor (NGF) in controls and patients suffering from primary or secondary Raynaud's…”
Get more information

Unusual clinical presentation in two boys with cytochrome c oxidase deficiency by HREBICEK, M, ZEMAN, J, PETRAK, B, KOZICH, V, HYANEK, J, RUITER, J. P. N, WANDERS, R. J. A, WIJBURG, F. A

Get full text

Quality management in the prophylaxis of venous thrombembolism--results of a survey including 464 medical and surgical patients by Klein-Weigel, P, Richter, J, Arendt, U, Gerdsen, F, Härtwig, A, Gutsche-Petrak, B, Walter, C, Santarelli, A, Glöckner, D, Hannemann, A, Hermanns, M, Leimbach, T, Rakob, J, Hullmeine, D, Jordan, A, Wiegand, J, Lenke, B, Lochmann, U A, Grunwald, H, Brackertz, R, Jäger, B, Bublak, A, Brand, T, Alsen, H

“…We surveyed the quality of risk stratification politics and monitored the rate of entries to our company-wide protocol for venous thrombembolism (VTE)…”
Get more information